Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $358.5000 (2.65%) ($348.4300 - $359.8900) on Fri. Jul. 1, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 44 | Latest Price | $358.5000(2.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.1% a day on average for past five trading days. | Weekly Trend | REGN declines -2.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(63%) XLV(50%) XBI(46%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.18% in a week (0% probabilities). VIXM(-10%) UUP(-8%) TLT(-7%) IPO(-6%) SHY(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
1 - 5 Day Possible Target | $342.3(-4.52%) | Resistance Level | $360.76 | 5 Day Moving Average | $345.28(3.83%) | 10 Day Moving Average | $347.28(3.23%) | 20 Day Moving Average | $360.76(-0.63%) | To recent high | -16.1% | To recent low | 8.3% | Market Cap | $38.011b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |